These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 19330172)
1. The impact of gene expression on 18F-FDG kinetics; a new chapter for diagnostic nuclear medicine. Strauss LG; Dimitrakopoulou-Strauss A Hell J Nucl Med; 2009; 12(1):2-4. PubMed ID: 19330172 [TBL] [Abstract][Full Text] [Related]
2. Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors. Strauss LG; Koczan D; Klippel S; Pan L; Cheng C; Willis S; Haberkorn U; Dimitrakopoulou-Strauss A J Nucl Med; 2008 Aug; 49(8):1238-44. PubMed ID: 18632818 [TBL] [Abstract][Full Text] [Related]
10. [18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation. Buchmann I; Vogg AT; Glatting G; Schultheiss S; Möller P; Leithäuser F; Schulte M; Gfrörer W; Kotzerke J; Reske SN Cancer Biother Radiopharm; 2003 Jun; 18(3):327-37. PubMed ID: 12954120 [TBL] [Abstract][Full Text] [Related]
11. Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas. Guo J; Higashi K; Ueda Y; Oguchi M; Takegami T; Toga H; Sakuma T; Yokota H; Katsuda S; Tonami H; Yamamoto I J Nucl Med; 2006 Mar; 47(3):419-25. PubMed ID: 16513610 [TBL] [Abstract][Full Text] [Related]
12. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients. Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620 [TBL] [Abstract][Full Text] [Related]
13. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124 [TBL] [Abstract][Full Text] [Related]
14. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer. Been LB; Hoekstra HJ; Suurmeijer AJ; Jager PL; van der Laan BF; Elsinga PH Oral Oncol; 2009 Dec; 45(12):e211-5. PubMed ID: 19692292 [TBL] [Abstract][Full Text] [Related]
15. Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics. Strauss LG; Dimitrakopoulou-Strauss A; Haberkorn U J Nucl Med; 2003 Dec; 44(12):1933-9. PubMed ID: 14660719 [TBL] [Abstract][Full Text] [Related]
16. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975 [TBL] [Abstract][Full Text] [Related]
18. Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary. Kurokawa T; Yoshida Y; Kawahara K; Tsuchida T; Okazawa H; Fujibayashi Y; Yonekura Y; Kotsuji F Int J Cancer; 2004 May; 109(6):926-32. PubMed ID: 15027127 [TBL] [Abstract][Full Text] [Related]
19. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer. Wang H; Zhang J; Tian J; Qu B; Li T; Chen Y; Liu J; Wang S J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model. Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]